Stock BRTX BIORESTORATIVE THERAPIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages BioRestorative Therapies, Inc.

Equities

BRTX

US0906556065

Real-time Estimate Cboe BZX
Other stock markets
 13:46:13 2024-06-27 EDT 		5-day change 1st Jan Change
1.84 USD -8.91% Intraday chart for BioRestorative Therapies, Inc. -13.40% +4.03%
01:40pm BioRestorative Therapies, Inc. Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program CI
06-13 Top Midday Gainers MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioRestorative Therapies, Inc. Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program
Top Midday Gainers
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
Sector Update: Health Care
BioRestorative Therapies in Licensing Talks for Metabolic Disease Program -- Shares Rise Pre-Bell
Exchange-Traded Funds Edge Higher, Equity Futures Mixed Pre-Bell Thursday Ahead of Key Economic Data
BioRestorative Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
BioRestorative Announces Signing a Five-Year Exclusive Supply Agreement with Cartessa Aesthetics, LLC
BioRestorative Therapies, Inc. Enhances Preclinical Metabolic Program with A Novel Exosome-Based Biologic Targeting Obesity
BioRestorative Therapies, Inc. Announces Transformative Commercial Agreement with Cartessa Aesthetics, LLC
BioRestorative Therapies, Inc. Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
BioRestorative Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society 2024 Annual Meeting
Top Midday Decliners
Top Premarket Decliners
BioRestorative Therapies Reports Positive Results From Lumbar Disc Treatment Candidate Trial; Shares Rise
BioRestorative Therapies, Inc. Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
BioRestorative Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Sector Update: Health Care Stocks Lower Late Afternoon
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BRTX Stock
  4. News BioRestorative Therapies, Inc.
  5. Other languages